Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors

NCT01166035 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT01166035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01166035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors
Lead sponsor
Medical University Innsbruck
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2010
Completion date
December 31, 2011
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors